StonvexLoading…
StonvexStonvexStonvexCore line items from RMBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $707.63M | $556.62M | $461.12M | $454.79M |
Operating Income | $260.22M | $183.01M | $153.64M | $76.94M |
Net Income | $230.46M | $179.82M | $333.90M | $-14.31M |
EPS (Diluted) | $2.11 | $1.65 | $3.01 | $-0.13 |
Total Assets | $1.53B | $1.34B | $1.26B | $1.01B |
Total Liabilities | $165.12M | $222.44M | $220.13M | $233.30M |
Cash & Equivalents | $182.82M | $99.77M | $94.77M | $125.34M |
Free Cash Flow OCF − CapEx | $333.18M | $199.90M | $172.55M | $212.91M |
Shares Outstanding | 107.78M | 106.84M | 107.85M | 107.61M |